Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anaplastic thyroid carcinoma

Known as: thyroid cancer, undifferentiated carcinoma, Dedifferentiated Thyroid Gland Carcinoma, Carcinomas, Anaplastic Thyroid 
An aggressive THYROID GLAND malignancy which generally occurs in IODINE-deficient areas in people with previous thyroid pathology such as GOITER. It… Expand
National Institutes of Health

Related topics

Related topics

25 relations
Anaplastic Carcinoma CellBlood supply aspectsCoagulative necrosisDeglutition Disorders
Expand

Narrower (1)

Anaplastic Giant Cell Thyroid Carcinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
BACKGROUND In a phase 2 trial, lenvatinib, an inhibitor of VEGF receptors 1-3, FGF receptors 1-4, PDGF receptor α, RET, and KIT… Expand
Review
2008
Review
2008
Malignant gliomas in adults.
  • P. Wen, S. Kesari
  • The New England journal of medicine
  • 2008
    • Corpus ID: 41225938
Approximately 5% of patients with malignant gliomas have a family history of gliomas. Some of these familial cases are associated… Expand
  • figure 1
  • figure 2
  • figure 4
  • table 1
  • table 2
Highly Cited
2005
Highly Cited
2005
Anaplastic thyroid carcinoma
Anaplastic thyroid carcinoma (ATC) is rare but is one of the most aggressive human malignancies. Several prognostic factors have… Expand
Highly Cited
2003
Highly Cited
2003
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
Thyroid papillary cancers (PTCs) are associated with activating mutations of genes coding for RET or TRK tyrosine kinase… Expand
  • table 1
  • figure 1
  • table 2
Highly Cited
2000
Highly Cited
2000
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
BACKGROUND Postoperative radiotherapy for International Federation of Gynaecology and Obstetrics (FIGO) stage-1 endometrial… Expand
Highly Cited
1998
Highly Cited
1998
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995
The National Cancer Data Base (NCDB) represents a national electronic registry system now capturing nearly 60% of incident… Expand
Highly Cited
1993
Highly Cited
1993
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
The development and progression of thyroid tumors is signaled by phenotype-specific mutations of genes involved in growth control… Expand
  • figure 1
  • figure 2
  • table I
  • figure 4
Highly Cited
1991
Highly Cited
1991
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.
Classification criteria for most of the disorders belonging to the spondylarthropathy group already exist. However, the spectrum… Expand
Highly Cited
1978
Highly Cited
1978
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
A controlled, prospective, randomized study evaluated the use of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and/or radiotherapy… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
1959
Highly Cited
1959
Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity.
ABSTRACT Medullary carcinoma is characterized by a solid nonfollicular histologic pattern, the presence of amyloid in the stroma… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE